Brief: Bliss GVS Pharma Sept-Quarter Consol Net Profit 272.5 Million Rupees
06/11/2025 15:32
Nov 6 (Reuters) - Bliss GVS Pharma Ltd BLIS.NS: BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL NET PROFIT 272.5 MILLION RUPEES BLISS GVS PHARMA LTD SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.44 BILLION RUPEES Source text: ID:nBSE7g0K3j Further company coverage: BLIS.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bliss GVS Pharma
See all newsBrief: Bliss GVS Pharma June-Quarter Consol Net Profit 501 Million Rupees
Brief: Bliss GVS Pharma Appoints Rahul Adakmol As CEO Effective July 15, 2026
Brief: Bliss GVS Pharma Says Received Inspection Closure Report From World Health Organization
India's Bliss GVS Pharma gains on Anupam Rasayan's plan to buy stake
Brief: Bliss GVS Pharma Dec-Quarter Consol Net Profit 232.7 Million Rupees